Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cymat Technologies Ltd CYMHF


Primary Symbol: V.CYM

Cymat Technologies Ltd. is a manufacturing company. The Company holds licenses and related patents to manufacture and sell Stabilized Aluminum Foam (SAF), a cellular metallic material. SAF is produced utilizing a process in which gas is bubbled into molten alloyed aluminum containing a dispersion of fine ceramic particles to create foam, which is then cast into strong, lightweight panels and... see more

TSXV:CYM - Post Discussion

Cymat Technologies Ltd > Historical Financials
View:
Post by Hopefulhomerun on Mar 23, 2021 1:33pm

Historical Financials

Revenue and Net Loss figuers:

Fiscal year ending April 30, 2016 = $1,354,000 in Revenue .... $1,513,000 net loss
Fiscal year ending April 30, 2017 = $2,751,000 in Revenue .... $1,043,000 net loss
Fiscal year ending April 30, 2018 = $3,046,000 in Revenue .... $1,116,000 net loss
Fiscal year ending April 30, 2019 = $2,643,000 in Revenue .... $1,359,000 net loss
Fiscal year ending April 30, 2020 = $1,687,000 in Revenue .... $1,814,000 net loss

So far, for the 1st 9 months of fiscal year 2021, revenue = $2,497,000 and net loss = $174,000.
Projected revenue for full year for 2021 sounds like it will be atleast $3,500,000..

So, from a revenue and net loss perspective, they look like they are heading in the right direction, and they should have their best year in a long time. However, and in addition to Alusion, they certainly need to hit on one of their other initiatives in order make things exciting/worthwhile.

Fingers crossed, and GLTA
Comment by woodman4 on Mar 23, 2021 8:05pm
I wonder if anyone has a sense on what other area is most likely to see success? 
Comment by aneleg on Mar 24, 2021 9:25am
Me sense that Alucoil is the opportunity that is the most realistic, but it is being delayed once again. Teseract made excellent advance in a short time. If they get an order it will open a huge opportunity. Military order would be great and reasonably certain as well as the bullets, but these will not be a home run
Comment by aneleg on Mar 24, 2021 11:01am
Me sense that Alucoil is the opportunity that is the most realistic, but it is being delayed once again. Teseract made excellent advance in a short time. If they get an order it will open a huge opportunity. Military order would be great and reasonably certain as well as the bullets, but these will not be a home run
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities